首页> 美国卫生研究院文献>Frontiers in Immunology >HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance
【2h】

HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance

机译:保守抗原决定簇的HLA偏爱:丙型肝炎清除的潜在机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatitis C virus (HCV) infections affect more than 170 million people worldwide. Most of these individuals are chronically infected, but some clear the infection rapidly. Host factors seem to play a key role in HCV clearance, among them are the human leukocyte antigen (HLA) class I molecules. Certain HLA molecules, e.g., B*27 and B*57, are associated with viral clearance. To identify potential mechanisms for these associations, we assess epitope distribution differences between HLA molecules using experimentally verified and in silico predicted HCV epitopes. Specifically, we show that the NS5B protein harbors the largest fraction of conserved regions among all HCV proteins. Such conserved regions could be good targets for cytotoxic T-cell (CTL) responses. We find that the protective HLA-B*27 molecule preferentially presents cytotoxic T-cell (CTL) epitopes from NS5B and, in general, presents the most strongly conserved epitopes among the 23 HLA molecules analyzed. In contrast, HLA molecules known to be associated with HCV persistence do not have similar preferences and appear to target the variable P7 protein. Overall, our analysis suggests that by targeting highly constrained – and thereby conserved – regions of HCV, the protective HLA molecule HLA-B*27 reduces the ability of HCV to escape the cytotoxic T-cell response of the host. For visualizing the distribution of both experimentally verified and predicted epitopes across the HCV genome, we created the HCV epitope browser, which is available at theory.bio.uu.nl/ucqi/hcv.
机译:丙型肝炎病毒(HCV)感染影响了全球超过1.亿7亿7千万人。这些人大多数是慢性感染的,但有些人可以迅速清除感染。宿主因素似乎在HCV清除中起关键作用,其中包括人类白细胞抗原(HLA)I类分子。某些HLA分子(例如B * 27和B * 57)与病毒清除率相关。为了确定这些关联的潜在机制,我们使用实验验证和计算机预测的HCV表位评估HLA分子之间的表位分布差异。具体而言,我们表明NS5B蛋白在所有HCV蛋白中均具有最大的保守区比例。此类保守区可能是细胞毒性T细胞(CTL)反应的良好靶标。我们发现,保护性HLA-B * 27分子优先呈现来自NS5B的细胞毒性T细胞(CTL)表位,并且通常呈现出所分析的23种HLA分子中最保守的表位。相反,已知与HCV持续性相关的HLA分子没有相似的偏好,并且似乎靶向可变的P7蛋白。总体而言,我们的分析表明,通过靶向高度受约束的HCV区域,从而保护了HCV的保守区域,保护性HLA分子HLA-B * 27降低了HCV逃脱宿主细胞毒性T细胞反应的能力。为了可视化HCV基因组中经过实验验证和预测的表位的分布,我们创建了HCV表位浏览器,可从theory.bio.uu.nl/ucqi/hcv获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号